What is an appropriate initial management approach for a child with presumed reactive cervical lymphadenopathy?

What is an appropriate initial management approach for a child with presumed reactive cervical lymphadenopathy?

• A. Observation without antibiotics
• B. Immediate surgical biopsy
• C. Immediate CT scan
• D. Empiric antibiotic therapy with observation for 4 weeks

Answer: (D)

In children, many cervical lymph nodes enlarge benignly from viral or inflammatory processes, so the initial step is to address a possible bacterial cause without jumping to invasive testing. Starting empiric antibiotics that cover common pathogens (strep and staph) and watching for a response over several weeks is the most balanced approach. If the node improves, continue the plan and reassess as symptoms evolve. If there’s no improvement, or if red flags appear (rapid growth, hard fixed nodes, supraclavicular location, fever, weight loss, or lasting several weeks despite therapy), then move on to imaging or biopsy. So, starting empiric antibiotic therapy with careful observation for about four weeks makes sense: it treats a probable bacterial component while avoiding unnecessary procedures in a child with presumed reactive lymphadenopathy.

In children, many cervical lymph nodes enlarge benignly from viral or inflammatory processes, so the initial step is to address a possible bacterial cause without jumping to invasive testing. Starting empiric antibiotics that cover common pathogens (strep and staph) and watching for a response over several weeks is the most balanced approach. If the node improves, continue the plan and reassess as symptoms evolve. If there’s no improvement, or if red flags appear (rapid growth, hard fixed nodes, supraclavicular location, fever, weight loss, or lasting several weeks despite therapy), then move on to imaging or biopsy.

So, starting empiric antibiotic therapy with careful observation for about four weeks makes sense: it treats a probable bacterial component while avoiding unnecessary procedures in a child with presumed reactive lymphadenopathy.